Zynerba Pharmaceuticals, Inc. (ZYNE): Price and Financial Metrics
ZYNE Price/Volume Stats
| Current price | $1.30 | 52-week high | $1.40 |
| Prev. close | $1.27 | 52-week low | $0.25 |
| Day low | $1.26 | Volume | 862,700 |
| Day high | $1.34 | Avg. volume | 515,333 |
| 50-day MA | $1.14 | Dividend yield | N/A |
| 200-day MA | $0.61 | Market Cap | 70.12M |
ZYNE Stock Price Chart Interactive Chart >
Zynerba Pharmaceuticals, Inc. (ZYNE) Company Bio
Zynerba Pharmaceuticals is a specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company was founded in 2007 and is based in Devon, Pennsylvania.
ZYNE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 14.04% |
| 5-year | -65.15% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -81.60% |
| 2021 | -12.73% |
| 2020 | -45.36% |
Continue Researching ZYNE
Here are a few links from around the web to help you further your research on Zynerba Pharmaceuticals Inc's stock as an investment opportunity:Zynerba Pharmaceuticals Inc (ZYNE) Stock Price | Nasdaq
Zynerba Pharmaceuticals Inc (ZYNE) Stock Quote, History and News - Yahoo Finance
Zynerba Pharmaceuticals Inc (ZYNE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...